基于GRADE的急诊科降钙素原应用指南
降钙素原是感染的有用生物标志物,过去二十年大量研究多在重症监护环境完成;尽管急诊科广泛使用降钙素原,此前没有专门针对急诊场景的指南,且既往指南多由专家共识主导、很少纳入循证医学概念。本指南先通过专家投票确定急诊使用降钙素原最关键的问题,随后进行系统文献综述并用GRADE方法评价证据水平,由指南制定组汇总评价单项研究特征以确定总体证据质量,按GRADE工作组分类系统将证据质量分为四级,并在明确考虑既定标准的基础上形成推荐。这是首部在急诊科应用降钙素原、采用循证医学原则并涵盖最新文献的指南。
要点
- 本指南针对急诊科降钙素原使用,是首部专门聚焦急诊场景的降钙素原指南。
- 关键临床问题通过专家投票确定,随后进行系统文献综述。
- 证据评价采用GRADE方法,证据质量按GRADE分类系统分为四级。
- 推荐在明确考虑既定标准的基础上形成,并透明评估推荐强度与潜在注意事项。
- 既往降钙素原研究多在重症监护环境进行,既往指南多由专家共识主导、很少纳入循证医学概念。
适用人群与场景
- 急诊科使用降钙素原的临床场景。
研究设计与关键结果
- 制定方法:先通过专家投票确定急诊使用降钙素原最关键的问题,随后进行系统文献综述并用GRADE方法评价证据水平。
- 由指南制定组汇总并评价单项研究的关键特征,以确定总体证据质量。
- 采用GRADE工作组分类系统将证据质量评为四级,推荐在明确考虑既定标准的基础上形成。
证据类型、等级与局限
- 证据类型:指南,采用GRADE方法进行证据评价与推荐形成。
- 证据质量按GRADE工作组分类系统分为四级。
- 局限:原文未报告局限性。
指南或共识出处
- 基于GRADE的急诊科降钙素原应用指南(GRADE-based procalcitonin guideline for emergency departments),发表于Am J Emerg Med。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Procalcitonin is a useful biomarker for infection. Over the past two decades, there has been much research on the clinical applications of procalcitonin, yet the majority of these studies have been conducted in the intensive care setting. Despite the extensive use of procalcitonin in emergency departments, there have been no guidelines focusing specifically on these clinical settings. Additionally, previous guidelines were predominantly shaped by expert consensus and rarely incorporate evidence-based medicine concepts. To address these shortcomings, the current guideline adopts a novel approach. Initially, we identified the most critical questions regarding the use of procalcitonin in emergency settings through expert voting. This was followed by a systematic literature review and the evaluation of evidence levels using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology. Key characteristics of individual studies will be summarized and evaluated by the guideline development group to determine the overall quality of evidence. The GRADE working group's categorization system will be employed to rate evidence quality into four levels. Recommendations will be formulated based on explicit consideration of established criteria. This structured approach ensures that guideline recommendations are founded on robust evidence and transparently assessed for strength and potential caveats. This is the first guideline on the use of procalcitonin to be applied in emergency departments that adopts the principles of evidence-based medicine and encompasses the up-to-date literatures, and it marks an advancement in providing guidance on the utilization of procalcitonin in emergency departments.
参考来源
- Lee CC, Porta L, Liu Y, et al. GRADE-based procalcitonin guideline for emergency departments. Am J Emerg Med. 2024. PMID: 39705853. doi:10.1016/j.ajem.2024.11.093
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。